Business:
Cancer Treatments
Drug notes:
AB-2100 Clin0 solid tumors
About:
ArsenalBio is developing programmable immune cell therapies to defeat cancer. CAR T-cell therapies are a recent revelation in developing targeted immune therapies for cancer. However, they have high risk and are high cost for development. Using multi-omics, gene editing technology and synthetic biology, ArsenalBio’s cell therapeutics are optimized for expansion, memory and persistence in vivo to reduce the number of cell infusions and minimize off-target effects. ArsenalBio is therefore enhancing the safety, efficacy and availability of these cell therapies for cancer patients. ArsenalBio has a multi program discovery collaboration with Bristol Myers Squibb to advance T cell therapies for solid tumors.
Director, Process Engineering (25105-T-680-PS) Hayward|18 days ago
Materials Technician I/II, Contract (25316-T-685-S... South San Francisco|21 days ago
Master Maintenance Mechanic, Contract (25314-T-689... Hayward|31 days ago
Director, Program Management (25103-R-615-MED) South San Francisco|31 days ago
Senior Research Associate II, Vivarium Operations,... South San Francisco|36 days ago
Director of GMP Procurement & Planning (25034-... Hayward|59 days ago
Senior Manager, Facilities & Engineering (Comp... Hayward|66 days ago
Don't See Your Role Below? South San Francisco|100+ days ago